Cargando…
DCvax: A promising advancement in oncology for the treatment of glioblastoma
Autores principales: | Fareed, Areeba, Rohail, Samia, Adnan, Alishba, Khan, Abdul Moiz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225952/ https://www.ncbi.nlm.nih.gov/pubmed/37256198 http://dx.doi.org/10.1177/20363613231179541 |
Ejemplares similares
-
Nirogacestat and its potential impact on desmoid tumor
por: Rohail, Samia, et al.
Publicado: (2023) -
DCVax-L Vaccination in Patients with Glioblastoma: Real Promise or Negative Trial? The Debate Is Open
por: Gatto, Lidia, et al.
Publicado: (2023) -
Type 2 diabetes drug glitazone may help lowering risk of dementia by 22%
por: Fareed, Areeba, et al.
Publicado: (2023) -
The Expanding Role of GLP-1: From Diabetes Management to Cancer Treatment
por: Fareed, Areeba, et al.
Publicado: (2023) -
Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence
por: Shahnoor, Syeda, et al.
Publicado: (2023)